Former Medtronic Spine and Biologics exec appointed DiscGenics CFO

Spinal Tech

Biopharmaceutical company DiscGenics has named Jeff Poole as its first CFO, according to a Sept. 9 news release.

Four things to know:

1. Mr. Poole has held several executive roles at Medtronic over a 13-year period.

2. Most recently, he served as vice president of finance for Medtronic Spine and Biologics, a global business unit with more than $2.5 billion in annual revenue.

3. Mr. Poole speaks fluent Japanese and has lived and worked in Japan, where DiscGenics has a significant commercial interest.

4. DiscGenics has secured more than $71 million in funding to date and is focusing on clinical trials of its allogeneic, injectable disc cell therapy for lumbar degenerative disc disease.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers